Loading clinical trials...
Loading clinical trials...
The purpose of this study is to see what effects, good and/or bad, proton radiation, and/or conventional radiation and hormonal therapy (if applicable), has on prostate cancer that has already returne...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Proton Collaborative Group
Collaborators
NCT07580196 · Prostate Cancer
NCT06787053 · Bladder (Urothelial, Transitional Cell) Cancer, Prostate Cancer
NCT06616155 · Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, and more
NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more
NCT07181122 · Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Proton Center of Arkansas
Little Rock, Arkansas
University of Florida Proton Therapy Institute
Jacksonville, Florida
Northwestern Medicine Chicago Proton Center
Warrenville, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions